Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Curbline Properties | CURB | Nov 25, 2024 | 23.95 | 0.00 |
Curevac N.V. | CVAC | Nov 25, 2024 | 2.77 | +4.14 |
CuriosityStream | CURI | Nov 25, 2024 | 1.80 | -0.55 |
Curis | CRIS | Nov 25, 2024 | 4.11 | +1.99 |
CURRENC Group | CURR | Nov 25, 2024 | 1.75 | 0.00 |
Curtiss-Wright | CW | Nov 25, 2024 | 371.38 | +0.15 |
Cushing Mlp & Infrastructure Total Return Fund | SRV | Nov 25, 2024 | 44.37 | -0.05 |
Cushman & Wakefield | CWK | Nov 25, 2024 | 15.17 | +5.06 |
Custom Truck One Source | CTOS | Nov 25, 2024 | 5.88 | +2.80 |
Customers Bancorp | CUBI | Nov 25, 2024 | 57.66 | +2.76 |
Customers Bancorp E Pref | CUBI-E | Nov 25, 2024 | 26.19 | -0.23 |
Customers Bancorp F Pref | CUBI-F | Nov 25, 2024 | 25.79 | +0.24 |
Cutera | CUTR | Nov 25, 2024 | 0.33 | +2.84 |
CVB Financial | CVBF | Nov 25, 2024 | 24.00 | +0.71 |
CVD Equipment | CVV | Nov 25, 2024 | 3.06 | -0.97 |
CVR Energy | CVI | Nov 25, 2024 | 19.28 | +2.88 |
Cvr Partners LP Unit | UAN | Nov 25, 2024 | 71.32 | -0.68 |
CVRx | CVRX | Nov 25, 2024 | 15.53 | +4.58 |
CVS Health | CVS | Nov 25, 2024 | 60.08 | +3.57 |
CXApp A | CXAI | Nov 25, 2024 | 1.43 | +1.42 |
CyberArk Software | CYBR | Nov 25, 2024 | 324.37 | +1.45 |
Cybin | CYBN | Nov 25, 2024 | 10.64 | +8.35 |
Cyclacel Pharmaceuticals | CYCC | Nov 25, 2024 | 0.34 | -3.37 |
Cyclacel Pharmaceuticals Pref | CYCCP | Nov 25, 2024 | 6.94 | 0.00 |
Cyclerion Therapeutics | CYCN | Nov 25, 2024 | 1.45 | +1.40 |
Cyclo Therapeutics | CYTH | Nov 25, 2024 | 0.68 | -7.23 |
Cyngn | CYN | Nov 25, 2024 | 6.42 | +5.25 |
Cytek Biosciences | CTKB | Nov 25, 2024 | 6.69 | +2.14 |
Cytokinetics | CYTK | Nov 25, 2024 | 50.25 | +2.34 |
Cytomed Therapeutics | GDTC | Nov 25, 2024 | 2.20 | -2.63 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.